Pharma Journalist -

Eagle Pharmaceuticals announced that the Company’s Eagle Biologics division has been issued a new patent by the United States Patent and Trademark Office (USPTO). Patent number…
Read More...

Are you looking for new business partners, extending your distributor network or sourcing specific products on the Chinese pharma market? We can support you on this! The upcoming…
Read More...

The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved…
Read More...

Organovo Holdings announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of highly specialized human liver cells, entered a non-exclusive global…
Read More...

Abzena plc, the life sciences group providing services and technologies to enable the design, development and manufacture of biopharmaceutical products, has announced the completion of…
Read More...

GlaxoSmithKline plc announces that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion (£9.2…
Read More...

ViiV Healthcare announced that the European Committee for Medicinal Products for Human Use (CHMP) has issued a Positive Opinion recommending marketing authorisation for Juluca…
Read More...

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Lialda (mesalamine) delayed-release tablets, 1.2 g, in the U.S. Mesalamine delayed-release tablets…
Read More...

Arrowhead Pharmaceuticals announced that it has dosed the first subjects in a Phase 1/2 clinical study of ARO-HBV, which is being developed as a potentially curative therapy for…
Read More...

Syngene International announced an R&D agreement with GSK. The multiyear agreement will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services…
Read More...